hat
Orlistat se yon pankreyas pankreyas ak gastric lipase inhibitor. Tout trigliserid dyetetik yo metabolize avèk èd nan lank pankreyas ak gastric. Lipasen yo enzymatique kraze trigliserid yo nan asid gra gratis ki ka pita dwe absòbe nan trip ti. Gastric ak pankreyas lipaz inhibiteur fòme lyezon ak pankreyas la ak gastric lipase nan lumineux nan trip la ti ak lestomak fè sa yo anzim kapab travay kòrèkteman.
eng
Orlistat is a potent pancreatic and gastric lipase inhibitor. All dietary triglycerides are metabolized with the aid of pancreatic and gastric lipases. The lipases enzymatically break down the triglycerides into free fatty acids that can later be absorbed in small intestines. Gastric and pancreatic lipase inhibitors form bonds with the pancreatic and gastric lipases in the lumen of the small intestine and stomach making these enzymes unable to work correctly.